|
|
Volumn 20, Issue 11, 2001, Pages 835-836
|
|
Early-stage elephantiasis in bancroftian filariasis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALBENDAZOLE;
ANTIBODY;
ANTIHISTAMINIC AGENT;
DIETHYLCARBAMAZINE;
IMMUNOGLOBULIN E;
IVERMECTIN;
STEROID;
ADULT;
AFRICA;
ANTIGEN DETECTION;
ARTICLE;
CASE REPORT;
CELL COUNT;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC PROCEDURE;
DRUG EFFICACY;
EDEMA;
ELEPHANTIASIS;
EOSINOPHIL;
FAMILY;
FILARIASIS;
FOLLOW UP;
HIGH RISK POPULATION;
HUMAN;
HUMAN CELL;
HYPOTENSION;
LABORATORY DIAGNOSIS;
LOA LOA;
MALE;
PHYSICAL EXAMINATION;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
PRURITUS;
RASH;
TRAVEL;
TREATMENT INDICATION;
WUCHERERIA BANCROFTI;
ADULT;
ALBENDAZOLE;
ANIMALS;
DEVELOPING COUNTRIES;
DRUG THERAPY, COMBINATION;
ELEPHANTIASIS, FILARIAL;
ENDEMIC DISEASES;
FILARICIDES;
FOLLOW-UP STUDIES;
HUMANS;
IVERMECTIN;
MALE;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
SOUTH AFRICA;
TRAVEL;
TREATMENT OUTCOME;
WUCHERERIA BANCROFTI;
|
|
EID: 0035663138
PISSN: 09349723
EISSN: None
Source Type: Journal
DOI: 10.1007/s100960100619 Document Type: Article |
|
Times cited : (6)
|
|
References (7)
|
